[1]
D. Khalid Ibrahim, دعاء, N. Akram Yahya, and نورالهدى, “Effects of Epigallocatechin-3-Gallate (EGCG) in Diabetes Mellitus as a DYRK1A inhibitor”, Iraqi J. Pharm., vol. 20, no. 2, pp. 168–173, Dec. 2023.